Search Articles
SAN FRANCISCO — A federal judge on Thursday dismissed antitrust claims that Gilead Sciences and its cronies blocked a cheap HIV drug from reaching patients, after the AIDS Healthcare Foundation missed the deadline to amend its complaint.
Categories /
Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.